- Home
- OMCL
as 01-21-2025 4:00pm EST
Omnicell Inc provides automation and business analytics software for healthcare providers. It helps its customers to define and deliver cost-effective medication management that is designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks, and to drive improved clinical, operational, and financial outcomes across all care settings. Omnicell generates the vast majority of its revenue in the United States.
| Founded: | 1992 | Country: | United States |
| Employees: | N/A | City: | FORT WORTH |
| Market Cap: | 2.0B | IPO Year: | 2001 |
| Target Price: | $50.00 | AVG Volume (30 days): | 489.8K |
| Analyst Decision: | Buy | Number of Analysts: | 6 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.39 | EPS Growth: | N/A |
| 52 Week Low/High: | $25.12 - $55.75 | Next Earning Date: | 02-06-2025 |
| Revenue: | $1,064,205,999 | Revenue Growth: | -10.26% |
| Revenue Growth (this year): | -1.75% | Revenue Growth (next year): | 5.24% |
Stock Insider Trading Activity of Omnicell Inc. ($0.001 par value) (OMCL)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| PARRISH MARK W | OMCL | Director | Dec 10 '24 | Sell | $47.30 | 12,000 | $567,638.40 | 58,427 |
Latest Omnicell Inc. ($0.001 par value) News
OMCL Breaking Stock News: Dive into OMCL Ticker-Specific Updates for Smart Investing
Argus Research
7 days ago
OMCL: Lowering target price to $44.00
Business Wire
9 days ago
Omnicell to Release Fourth Quarter and Full Year 2024 Financial Results on February 6, 2025
Business Wire
14 days ago
Omnicell to Present at the 43rd Annual J.P. Morgan Healthcare Conference
MT Newswires
16 days ago
BofA Securities Adjusts Price Target on Omnicell to $46 From $54
Zacks
16 days ago
Omnicell Gains 26.2% in a Year: What's Driving the Stock?
Zacks
19 days ago
Reasons to Retain Phibro Stock in Your Portfolio Now
Zacks
19 days ago
Reasons to Retain Medtronic Stock in Your Portfolio Now
Zacks
20 days ago
Here's Why You Should Retain HOLX Stock in Your Portfolio Now
Compare OMCL vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "OMCL Omnicell Inc. ($0.001 par value) - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.